NCT05666362View on ClinicalTrials.gov

Hemodynamic Response to Pain During Retinopathy Of Prematurity Screening

PHASE4CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

January 20, 2023

Primary Completion Date

December 20, 2024

Study Completion Date

January 15, 2025

Conditions
Preterm
Interventions
DRUG

benoxinate hydrochloride 0.4% group

They will receive benoxinate hydrochloride 0.4% immediately before fundus

DRUG

saline 0.9% .

They will receive saline 0.9% before fundus examination in each eye .

Trial Locations (1)

0356

Marwa Mohamed Farag, Alexandria

All Listed Sponsors
lead

Alexandria University

OTHER